3+ day, 17+ hour ago   (264+ words) Sept 10 (Reuters) – The first horse in the United States to be infected with New World screwworm has been detected in southern Texas ​near the Mexican border, data from the U.S. ‌Department of Agriculture showed. The case of the flesh-eating…...

4+ day, 6+ hour ago   (278+ words) Sept 10 (Reuters) – Biohaven said on Thursday the U.S. FDA had imposed a partial clinical hold, pausing new patient enrollment in trials of its experimental ​epilepsy drug after rodent findings, sending its shares ‌down more than 13% in premarket trading. Here are…...

4+ day, 10+ hour ago   (146+ words) STOCKHOLM, Sept 10 (Reuters) - Denmark's Novo Nordisk said ​on Thursday ‌its blockbuster weight-loss drug Wegovy had been approved in ‌China ​as ⁠the first ⁠GLP-1 RA class of drugs for the treatment of ​metabolic dysfunction-associated steatohepatitis... STOCKHOLM, Sept 10 (Reuters) – Denmark’s…...

4+ day, 20+ hour ago   (253+ words) Sept 9 (Reuters) – The U.S. Food and Drug Administration said on Wednesday it was investigating a multistate outbreak of salmonella infections linked to broccoli ​sprouts, the latest in a series of ‌foodborne-illness investigations involving produce. This comes amidst an ongoing cyclosporiasis…...

6+ day, 1+ hour ago   (317+ words) Sept 8 (Reuters) – Shares of Dyne Therapeutics and Sarepta slumped on Tuesday after Novartis’ treatment for a muscle-wasting disorder failed in a trial, fueling investor concerns ​about the prospects of similar therapies for the tough-to-treat ‌rare disease. Dyne’s stock led declines…...

6+ day, 13+ hour ago   (652+ words) NEW DELHI, Sept 8 (Reuters) – India is witnessing an unprecedented food safety crackdown, with regulators forcing many local eateries and branded restaurants to suspend operations, while a push for front-of-pack warning labels has rattled the country’s more than $100 billion packaged food…...

1+ week, 6+ hour ago   (191+ words) Sept 7 (Reuters) – Novo Nordisk said on Monday it had halted two additional trials of its ​experimental cardiovascular drug ziltivekimab, further ‌denting the Danish drugmaker’s efforts to diversify beyond its blockbuster obesity and diabetes franchise. In July, Novo said ziltivekimab failed…...

1+ week, 7+ hour ago   (108+ words) COPENHAGEN, Sept 7 (Reuters) - Novo Nordisk said ​on ‌Monday that in a late-stage ‌trial, ​40.4% ⁠of children ⁠aged 6 to under 12 treated ​with semaglutide, ⁠the ⁠active ingredient ​in its ​blockbuster weight-loss drug ‌Wegovy, were no longer ⁠classifi... Novo Nordisk says semaglutide cut obesity…...

1+ week, 10+ hour ago   (145+ words) LONDON, Sept 7 (Reuters) – Shares of Novartis fell 3.3% on Monday morning after ​its cholesterol drug failed ‌in a closely watched study, casting fresh doubt on the therapeutic approach and raising the ‌stakes ​for the ⁠Swiss drugmaker’s upcoming ⁠data for a gene…...

1+ week, 11+ hour ago   (432+ words) NEW DELHI, Sept 7 (Reuters) – Indian activists spearheading calls for food labelling said a government proposal to have red warnings only when two concerning nutrients are high created an “industry-friendly loophole” disregarding public health, marking the first ​formal court objection to…...